InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+21.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Trenary C Russell III, Chairman & CEO. Officer active across 1 company, notably Outlook Therapeutics, Inc.. In total, 3 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €63k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 21 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Trenary C Russell III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
19,925 shares@ US$1.060.014% mcap18.9% of flowCommon StockSEC:0001209191-22-038985:0
Canonical exit: 19 Sept 2022 (T+90)
25,000 shares@ US$1.3948.7% of flowCommon StockSEC:0001209191-21-068137:0
Canonical exit: 6 Mar 2022 (T+90)
10,000 shares@ US$1.4019.6% of flowCommon StockSEC:0001209191-21-067644:0
Canonical exit: 2 Mar 2022 (T+90)
3 of 3 declarations
About Trenary C Russell III
C. Russell Trenary III is the Chief Executive Officer of Outlook Therapeutics, Inc. He leads the company with a strategic vision, focusing on innovation and growth. His leadership is crucial in guiding the company's initiatives in the biotechnology sector.
